Relx Plc (NYSE:RELX) Shares Sold by US Bancorp DE

Key Points

• US Bancorp DE has reduced its stake in RELX PLC by 7.1%, selling 18,641 shares to end with 242,369 shares valued at $12.2 million.
• Several other institutional investors also increased their holdings, with Larson Financial Group LLC raising its stake by 612.5% during the same quarter.
• RELX announced a semi-annual dividend of $0.2634 per share, payable on September 16th, representing a yield of 170.0% with a payout ratio of 65.05%.

US Bancorp DE trimmed its position in shares of Relx Plc (NYSE:RELX - Free Report) by 7.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 242,369 shares of the technology company's stock after selling 18,641 shares during the quarter. US Bancorp DE's holdings in Relx were worth $12,218,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Larson Financial Group LLC grew its stake in shares of Relx by 612.5% during the 1st quarter. Larson Financial Group LLC now owns 513 shares of the technology company's stock valued at $26,000 after purchasing an additional 441 shares during the period. Golden State Wealth Management LLC raised its position in Relx by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company's stock worth $30,000 after acquiring an additional 294 shares during the period. Cornerstone Planning Group LLC boosted its stake in shares of Relx by 325.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company's stock worth $37,000 after acquiring an additional 530 shares during the last quarter. Transce3nd LLC bought a new stake in shares of Relx during the 4th quarter valued at $40,000. Finally, Redwood Investments LLC bought a new stake in shares of Relx during the 4th quarter valued at $120,000. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Wall Street Zen raised shares of Relx from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy".

Relx Trading Up 1.0%

Shares of NYSE:RELX traded up $0.49 during trading on Thursday, reaching $49.30. 1,069,223 shares of the company were exchanged, compared to its average volume of 829,064. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The business's fifty day simple moving average is $53.01 and its 200-day simple moving average is $51.59. The firm has a market capitalization of $90.54 billion, a PE ratio of 26.50, a P/E/G ratio of 3.30 and a beta of 0.88. Relx Plc has a 12-month low of $44.19 and a 12-month high of $56.33.

Relx Cuts Dividend

The company also recently declared a semi-annual dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th will be issued a $0.2634 dividend. This represents a yield of 170.0%. The ex-dividend date of this dividend is Friday, August 8th. Relx's payout ratio is currently 27.96%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.